Saving changes...

Done

Error

Immunotherapy in Cancer Treatment

Immunotherapy in Cancer Treatment

Immunotherapy in Cancer Treatment

Pamela Clark
Pamela Clark
on behalf of Pedagogy Incorporated

$15.00 $ 15.00 $ 15.00

$15.00 $ 15.00 $ 15.00

$ 15.00 $ 15.00 $ 15.00
$ 15.00 $ 15.00 $ 15.00
Normal Price: $15.00 $15.00

Review:

Launch date: 20 Nov 2017
Expiry Date:

Last updated: 06 Sep 2018

Reference: 185308

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This instructional course has been designed for healthcare clinicians administering and/or caring for the patient receiving parenteral immunotherapy. All clinicians involved in infusing immunotherapeutic agents and those caring for patients receiving these medications need a working knowledge of the diagnoses for which they are given, side effects of the drugs, appropriate interventions, and the psychological implications of having these diseases and receiving treatment for them. These drugs are double-edged swords. They can treat cancer effectively but are also associated with significant and dangerous adverse effects. Therefore, education related specifically to immunotherapy is crucial to the safe and effective use of these drugs.

State Boards of Nursing have varying positions on the role of the LPN/LVN in the administration of infusion therapy, including the administration of immunotherapeutic agents. A link to each state board of nursing is listed here. Competency requirements are obtained and maintained through the nurse¹s employer, facility or institution.

Our continuing nursing education courses are accredited by the California Board of Registered Nurses, the Georgia Board of Nursing, and the Florida Board of Nursing. All states recognize our courses for accredited continuing education contact hours.

Objectives

On completion of this course, the learner will be able to:
1. State the relationship between monoclonal antibodies and cancer cell antigens.

2. Identify at least three different classes of immunotherapy used for the treatment of cancer.

3. Identify the recommended treatments/actions for immunotherapy adverse effects, both grades 1 or 2 and grades 3 or 4.

4. Explain the purpose of a REMS program.
Pamela Clark

Author Information Play Video Bio

Pamela Clark
on behalf of Pedagogy Incorporated

Pamela Clark, CRNI, is a Nurse Manager for Healix, a leader in the field of parenteral services. She has more than 28 years of experience in infusion therapy and infusion education with both licensed nurses and patients. Her experience spans multiple infusion settings including: acute care, long-term care, home infusion, and ambulatory infusion care. She also has experience in oncology and oncology research.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • California Board of Registered Nursing (CBRN)
  • 1.50 Hours
  • Georgia Board of Nursing
  • 1.50 Hours

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error